Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid Tumors (NEXTGENTIL-ACT)
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
No Comments.